FDA Authorizes 24 Velo Nicotine Pouch Products

Retailers and distributors of nicotine pouches gain newly authorized products and should review packaging expectations with qualified counsel.

Updated on Nov. 4, 2026 in Consumer Goods

FDA Authorizes 24 Velo Nicotine Pouch Products

Live Poll

Do you think nicotine pouches are a safer choice than smoking cigarettes?

The FDA authorized marketing of 24 Velo nicotine pouch products, reviewed under its nicotine pouch pilot program launched in September 2025. For consumer goods and tobacco retailers, the authorization opens a regulated path for these pouch products to be sold in the U.S.

Why it matters

The FDA says the pilot program streamlined its premarket tobacco application review while keeping scientific standards in place. The agency found the Velo products contain lower levels of harmful and potentially harmful constituents than cigarettes and smokeless tobacco products, which is the basis for the authorization.

The FDA authorized 24 Velo nicotine pouch products, while smokeless tobacco alternatives sales per store rose 35.5% year over year and other tobacco products sales per store grew 3.7% in 2025.

The players

U.S. Food and Drug Administration (FDA)

The federal agency that regulates tobacco products, including premarket review and authorization of nicotine products sold to U.S. consumers.

Velo

A nicotine pouch brand whose 24 products were authorized for marketing by the FDA.

The details

Under the pilot program, the FDA increased real-time communication with applicants, provided more frequent feedback, and worked to resolve application deficiencies earlier in the review. The agency found many constituents in the Velo products were present at levels too low to quantify and reported no measurable levels of several carcinogenic constituents. The FDA has also urged nicotine pouch manufacturers to use child-resistant packaging or other measures.

Timeline

  1. September 2025: FDA launches nicotine pouch pilot program.

  2. 2025: Other tobacco products sales per store grow 3.7%.

  3. November 4, 2026: FDA authorization of the 24 Velo products is reported.

Market Landscape

The authorization comes under the FDA's nicotine pouch pilot program, which launched in September 2025 to streamline premarket tobacco application review. Smokeless tobacco alternatives sales per store rose 35.5% year over year, placing nicotine pouches in a fast-growing segment of the tobacco category.

Retailers and distributors carrying nicotine pouches should review how the authorized Velo products fit into their assortment and whether packaging meets the FDA's child-resistance expectations. Operators should consult qualified counsel on any regulatory obligations tied to selling authorized tobacco products.

The takeaway

The pilot program shows the FDA moving authorization decisions faster while keeping its scientific review standards, which could shape timelines for other nicotine product applicants. Operators tracking this category should watch the FDA's packaging expectations and calendar any compliance steps with qualified counsel.

Further reading

For broader context on regulated consumer goods, see Consumer Goods coverage across the United States.

Source note: This article includes information reported by Convenience Store News.

Live Poll

Do you think nicotine pouches are a safer choice than smoking cigarettes?